Deciphering the genetics and mechanisms of predisposition to multiple myeloma

Nat Commun. 2024 Aug 5;15(1):6644. doi: 10.1038/s41467-024-50932-7.

Abstract

Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in a genome-wide association study totaling 10,906 cases and 366,221 controls, we identify 35 MM risk loci, 12 of which are novel. Through functional fine-mapping and Mendelian randomization, we uncover two causal mechanisms for inherited MM risk: longer telomeres; and elevated levels of B-cell maturation antigen (BCMA) and interleukin-5 receptor alpha (IL5RA) in plasma. The largest increase in BCMA and IL5RA levels is mediated by the risk variant rs34562254-A at TNFRSF13B. While individuals with loss-of-function variants in TNFRSF13B develop B-cell immunodeficiency, rs34562254-A exerts a gain-of-function effect, increasing MM risk through amplified B-cell responses. Our results represent an analysis of genetic MM predisposition, highlighting causal mechanisms contributing to MM development.

MeSH terms

  • B-Cell Maturation Antigen* / genetics
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Case-Control Studies
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study*
  • Humans
  • Male
  • Mendelian Randomization Analysis
  • Multiple Myeloma* / genetics
  • Polymorphism, Single Nucleotide*
  • Telomere / genetics
  • Transmembrane Activator and CAML Interactor Protein / genetics

Substances

  • B-Cell Maturation Antigen
  • TNFRSF13B protein, human
  • Transmembrane Activator and CAML Interactor Protein